首页> 外国专利> INHIBITION OF HISTONE DEACETYLASE AND TUMOR NECROSIS FACTOR CONVERTING ENZYME

INHIBITION OF HISTONE DEACETYLASE AND TUMOR NECROSIS FACTOR CONVERTING ENZYME

机译:组蛋白去乙酰化酶和肿瘤坏死因子转化酶的抑制

摘要

PPROBLEM TO BE SOLVED: To provide a composition and method effective for prevention and treatment of human diseases such as Huntington's chorea (HD), articular rheumatism, etc., associated to Histone Deacetylase ([HDAC]) and/or Tumor Necrosis Factor Converting Enzyme ([TACE]). PSOLUTION: The invention relates to the composition for inhibiting Histone Deacetylase ([HDAC]) and/or Tumor Necrosis Factor Converting Enzyme ([TACE]) in living organisms, more particularly, the invention relates to the compositions involving 0.1-99 wt.%. of processed Morinda citrifolia L. plant products. The processed Morinda citrifolia L. plant products are extracted by water, ethanol, steam distillation extract from leaves of the Morinda citrifolia and concentrated fruits juice, etc., and the preparation can be administered simultaneously with other pharmaceuticals in a method selected from oral, intervenous and systemic administeration. PCOPYRIGHT: (C)2007,JPO&INPIT
机译:

要解决的问题:提供有效预防和治疗与组蛋白脱乙酰酶([HDAC])和/或肿瘤坏死相关的人类疾病(如亨廷顿舞蹈病(HD),关节风湿病等)的组合物和方法因子转换酶([TACE])。解决方案:本发明涉及在活生物体中抑制组蛋白脱乙酰基酶([HDAC])和/或肿瘤坏死因子转化酶([TACE])的组合物,更具体地,本发明涉及涉及0.1-99的组合物。重量%。加工的巴戟天枸杞植物产品。用水,乙醇,巴戟天叶和浓缩果汁等中的水,乙醇,蒸汽蒸馏提取物提取加工后的巴戟天植物产品,该制剂可以与其他药物同时从口服,静脉内选择的方式给药。和全身管理。

版权:(C)2007,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号